Page last updated: 2024-11-07

prednisone and Primary Graft Dysfunction

prednisone has been researched along with Primary Graft Dysfunction in 1 studies

Prednisone: A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver.
prednisone : A synthetic glucocorticoid drug that is particularly effective as an immunosuppressant, and affects virtually all of the immune system. Prednisone is a prodrug that is converted by the liver into prednisolone (a beta-hydroxy group instead of the oxo group at position 11), which is the active drug and also a steroid.

Primary Graft Dysfunction: A form of ischemia-reperfusion injury occurring in the early period following transplantation. Significant pathophysiological changes in MITOCHONDRIA are the main cause of the dysfunction. It is most often seen in the transplanted lung, liver, or kidney and can lead to GRAFT REJECTION.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Guillén-Gómez, E1
Guirado, L1
Belmonte, X1
Maderuelo, A1
Santín, S1
Juarez, C1
Ars, E1
Facundo, C1
Ballarín, JA1
Vidal, S1
Díaz-Encarnación, MM1

Other Studies

1 other study available for prednisone and Primary Graft Dysfunction

ArticleYear
Monocyte implication in renal allograft dysfunction.
    Clinical and experimental immunology, 2014, Volume: 175, Issue:2

    Topics: Allografts; Antigens, CD; Antigens, Differentiation, Myelomonocytic; B7-2 Antigen; Creatinine; Femal

2014